Federal Register #DEA1753

DEA Notice: Chattem Chemicals Application for Bulk Manufacturing of Controlled Substances

This DEA notice concerns Chattem Chemicals' application to become a registered bulk manufacturer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEM/Vendor: - Chattem Chemicals - Products Requested: - Bulk manufacturing registration for multiple controlled substances - Substances include: - Gamma Hydroxybutyric Acid (Drug Code: 2010) - Marihuana (synthetic, Drug Code: 7360) - Tetrahydrocannabinols (synthetic, Drug Code: 7370) - 4-Methoxyamphetamine (Drug Code: 7411) - Dihydromorphine (Drug Code: 9145) - Amphetamine (Drug Code: 1100) - Methamphetamine (Drug Code: 1105) - Lisdexamfetamine (Drug Code: 1205) - Methylphenidate (Drug Code: 1724) - Cocaine (Drug Code: 9041) - Codeine (Drug Code: 9050) - Dihydrocodeine (Drug Code: 9120) - Oxycodone (Drug Code: 9143) - Hydromorphone (Drug Code: 9150) - Ecgonine (Drug Code: 9180) - Hydrocodone (Drug Code: 9193) - Levorphanol (Drug Code: 9220) - Methadone (Drug Code: 9250) - Methadone intermediate (Drug Code: 9254) - Morphine (Drug Code: 9300) - Oripavine (Drug Code: 9330) - Thebaine (Drug Code: 9333) - Oxymorphone (Drug Code: 9652) - Noroxymorphone (Drug Code: 9668) - Alfentanil (Drug Code: 9737) - Remifentanil (Drug Code: 9739) - Sufentanil (Drug Code: 9740) - Tapentadol (Drug Code: 9780) - Fentanyl (Drug Code: 9801) - 3,4-Methylenedioxy-N-methylcathinone (Drug Code: 7540) - No quantities specified; registration is for bulk manufacturing - Unique/Notable Requirements: - Synthetic production specified for Marihuana and Tetrahydrocannabinols - Compliance with local, state, and federal regulations required - Public comment and hearing requests are permitted before registration is finalized - No other activities authorized for these drug codes under this registration

Description

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The company plans to bulk manufacture the listed controlled substances to provide pharmaceutical-grade marihuana to facilitate research in compliance with local, state, and federal regulations. No other activities for these drug codes are authorized for this registration. Comments and requests for hearings are due by October 26, 2026.

View original listing